The influence of preanalytical conditions on the DJ-1 concentration in human cerebrospinal fluid

Pre-analytical factors influencing the stability of cerebrospinal fluid proteins

(2013) Anja H. Simonsen et al.   JOURNAL OF NEUROSCIENCE METHODS

Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update

(2012) Marta del Campo et al.   Biomarkers in Medicine

The DJ-1 concentration in cerebrospinal fluid does not differentiate among parkinsonian syndromes

(2012) Lisette Salvesen et al.   PARKINSONISM & RELATED DISORDERS

Diagnostic markers for Parkinsonʼs disease

(2011) Lama M. Chahine et al.   CURRENT OPINION IN NEUROLOGY

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

(2010) Min Shi et al.   ANNALS OF NEUROLOGY

DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

(2010) Zhen Hong et al.   BRAIN

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease

(2010) Min Shi et al.   NEUROSCIENCE LETTERS

Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson’s disease and major depression

(2009) Sven Pålhagen et al.   JOURNAL OF NEUROLOGY

Correlation between DJ-1 levels in the cerebrospinal fluid and the progression of disabilities in multiple sclerosis patients

(2008) M Hirotani et al.   Multiple Sclerosis Journal

DJ-1 Modulates α-Synuclein Aggregation State in a Cellular Model of Oxidative Stress: Relevance for Parkinson's Disease and Involvement of HSP70

(2008) Sara Batelli et al.   PLoS One

Secretion of DJ-1 into the serum of patients with Parkinson's disease

(2007) Chinatsu Maita et al.   NEUROSCIENCE LETTERS